Yutaka Okuno

Kumamoto University Hospital — Japan

Medicine · Health Sciences

22h-index2.4kcitations119works0.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Myeloma Research and Treatments(28), Acute Myeloid Leukemia Research(26), Chronic Myeloid Leukemia Treatments(12), Histone Deacetylase Inhibitors Research(11), Protein Degradation and Inhibitors(11)

Publications119 total

Human epididymal protein 4 reflects extracellular matrix accumulation and predicts the outcome of post-operative patients with severe aortic stenosis after transcatheter aortic valve implantation
European Heart Journal·2025
Human epididymis protein 4 contributes to lower systolic function and poor prognosis in heart failure with reduced ejection fraction
European Heart Journal·2025
The impact of a workplace dental-health program on glycemic control in Japanese working adults: a cohort study
BMC Oral Health·2025Open Access
Decreased PU.1 expression in mature B cells induces lymphomagenesis
Cancer Science·2024· 1 citedOpen Access
Data from Down-regulation of PU.1 by Methylation of Distal Regulatory Elements and the Promoter Is Required for Myeloma Cell Growth
2023Open Access
Data from Down-regulation of PU.1 by Methylation of Distal Regulatory Elements and the Promoter Is Required for Myeloma Cell Growth
2023Open Access
Supplementary Figure 1 Legend from Down-regulation of PU.1 by Methylation of Distal Regulatory Elements and the Promoter Is Required for Myeloma Cell Growth
2023Open Access
Supplementary Figure 1 Legend from Down-regulation of PU.1 by Methylation of Distal Regulatory Elements and the Promoter Is Required for Myeloma Cell Growth
2023Open Access
Supplementary Figure 1 from Down-regulation of PU.1 by Methylation of Distal Regulatory Elements and the Promoter Is Required for Myeloma Cell Growth
2023Open Access
Supplementary Figure 1 from Down-regulation of PU.1 by Methylation of Distal Regulatory Elements and the Promoter Is Required for Myeloma Cell Growth
2023Open Access
Blocking cholesterol efflux mechanism is a potential target for antilymphoma therapy
Cancer Science·2022· 16 citedOpen Access
Relationship between Serum Bortezomib Concentration and Emergence of Diarrhea in Patients with Multiple Myeloma and/or AL Amyloidosis
Cancers·2021· 1 citedOpen Access
Cooperative impact of Utx loss and Braf V600E mutation induces myeloma in mice
Clinical Lymphoma Myeloma & Leukemia·2019
Novel p97/<scp>VCP</scp> inhibitor induces endoplasmic reticulum stress and apoptosis in both bortezomib‐sensitive and ‐resistant multiple myeloma cells
Cancer Science·2019· 34 citedOpen Access
Clinical potential of dual-energy cardiac CT in cardiac amyloidosis
Amyloid·2019· 1 cited
IL-34の発現はびまん性大細胞型B細胞リンパ腫のマクロファージ浸潤および予後と相関する【JST・京大機械翻訳】
Clinical And Translational Immunology·2019
Expression of <scp>IL</scp>‐34 correlates with macrophage infiltration and prognosis of diffuse large B‐cell lymphoma
Clinical & Translational Immunology·2019· 16 citedOpen Access
新規p97/VCP阻害剤は,ボルテゾミブ感受性および耐性多発性骨髄腫細胞の両方で小胞体ストレスおよびアポトーシスを誘導する
Cancer Science (Web)·2019
[Spontaneous remission of acquired factor XIII inhibitor concurrent to development of IgA-λ type multiple myeloma].
PubMed·2019· 1 cited
Utx Insufficiency Cooperates with Braf V600E in the Induction of Myeloma in Mice
Blood·2018· 1 cited
page 1 of 6Next →

Frequent Co-authors

Hiroaki Mitsuya(23), Hiroyuki Hata(19), Yawara Kawano(12), Shinya Endo(11), Daniel G. Tenen(10), Kisato Nosaka(10), Hiro Tatetsu(10), Shikiko Ueno(10), Masao Matsuoka(9), Shiho Fujiwara(9), Koichi Akashi(8), Yoshitaka Kikukawa(8), Yoshihiro Komohara(8), Hiromichi Yuki(7), Motohiro Takeya(7), Naoko Wada(7), Nao Nishimura(7), Hiromi Iwasaki(6), Hanna S. Radomska(6), Niina Ueno(4)